Nuvalent Announces “OnTarget 2026” Operating Plan and Key Anticipated Milestones

January 8, 2024

https://www.prnewswire.com/news-releases/nuvalent-announces-ontarget-2026-operating-plan-and-key-anticipated-milestones-302028095.html

Targeting first approved product in 2026 towards realizing mission of bringing new, potential best-in-class treatments to patients with cancer

Well-capitalized to support OnTarget 2026 initiatives with operating runway anticipated into 2027

Read more at prnewswire.com

Related news for (NUVL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.